BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 31263129)

  • 21. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
    Cun J; Yang Q
    Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
    Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
    Lee J; Kim HE; Song YS; Cho EY; Lee A
    Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer.
    Han X; Li Q; Liu C; Wang C; Li Y
    J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing
    Zhang P; Yang Y; Qian K; Li L; Zhang C; Fu X; Zhang X; Chen H; Liu Q; Cao S; Cui J
    J Biol Chem; 2020 Oct; 295(41):14140-14152. PubMed ID: 32690611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways.
    Yin D; Kong C; Chen M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corylin sensitizes breast cancer cells to overcome tamoxifen resistance by regulating OAS1/miR-22-3p/SIRT1 axis.
    Che L; Yang H; Wang D; Liu S
    Acta Biochim Pol; 2021 Nov; 68(4):757-764. PubMed ID: 34731560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.
    Ikeda K; Horie-Inoue K; Ueno T; Suzuki T; Sato W; Shigekawa T; Osaki A; Saeki T; Berezikov E; Mano H; Inoue S
    Sci Rep; 2015 Aug; 5():13170. PubMed ID: 26255816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.
    Masri S; Liu Z; Phung S; Wang E; Yuan YC; Chen S
    Breast Cancer Res Treat; 2010 Nov; 124(1):89-99. PubMed ID: 20054641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.
    Martin EC; Conger AK; Yan TJ; Hoang VT; Miller DF; Buechlein A; Rusch DB; Nephew KP; Collins-Burow BM; Burow ME
    FEBS Lett; 2017 Jan; 591(2):382-392. PubMed ID: 28008602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.
    Zhang Y; He Y; Lu LL; Zhou ZY; Wan NB; Li GP; He X; Deng HW
    Kaohsiung J Med Sci; 2019 Jan; 35(1):17-23. PubMed ID: 30844143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.
    Wei Y; Lai X; Yu S; Chen S; Ma Y; Zhang Y; Li H; Zhu X; Yao L; Zhang J
    Breast Cancer Res Treat; 2014 Sep; 147(2):423-31. PubMed ID: 25007959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional roles of hnRNPA2/B1 regulated by METTL3 in mammalian embryonic development.
    Kwon J; Jo YJ; Namgoong S; Kim NH
    Sci Rep; 2019 Jun; 9(1):8640. PubMed ID: 31201338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells.
    Muluhngwi P; Klinge CM
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.